Jeff Goater
InvestorPartner at The Column Group · Board director at RYNE Biotechnology Inc. · Board director at Remix Therapeutics
Boston, Massachusetts
Writes $100K – $5M checks · typically $1.5M
About
Jeff Goater leverages a career from research scientist to Evercore investment banker to biotech CEO, bringing deep technical, company-building expertise and a hands-on style as executive chair or interim CEO.
Contact· self-published, not guessed
Likely email· guessed from name + firm domain, not firm-published
- j•••@thecolumngroup.comreveal100% confident
Invests in
BiotechHealthtech
Board director at RYNE Biotechnology Inc.
Intro paths
→
In turn, Jeff can intro founders to RYNE Biotechnology Inc.'s investors below.
RYNE Biotechnology Inc.'s investors · 2
Board director at Remix Therapeutics
Intro paths
→
In turn, Jeff can intro founders to Remix Therapeutics's investors below.
Remix Therapeutics's investors · 5
Co-founders at Remix Therapeutics
PS
Peter Smith, PhDCo-Founder, President and Chief Executive Officer
PS
Peter SmithCo-Founder, President and Chief Executive Officer
Experience
- Judo BioBoard Membercurrent2026 — present
- Judo BioExecutive Chair2022 — 2026
- Tortugas NeuroscienceBoard Membercurrent2025 — present
- NILO TherapeuticsBoard Membercurrent2024 — present
- Kenai TherapeuticsBoard Membercurrent2024 — present
- The Column GroupPartnercurrent2024 — presentBoston, Massachusetts, United States
- The Column GroupVenture Partner2021 — 2023
- Remix TherapeuticsBoard Membercurrent2023 — present
- AviadoBioChaircurrent2023 — present
- KallyopeBoard Membercurrent2022 — present
- Topo TherapeuticsBoard Member2024 — 2026
- Atavistik BioBoard Member2021 — 2026Cambridge, Massachusetts, United States
- Atavistik BioInterim CEO2022 — 2023
- Ribon TherapeuticsBoard Member2021 — 2024Cambridge, MA
- Surface Oncology Inc.Board Member2018 — 2023Cambridge, Massachusetts, United States
- Surface Oncology Inc.CEO2018 — 2021Cambridge, MA
- Surface Oncology Inc.CBO2017 — 2018Cambridge, MA
- LogicBio TherapeuticsBoard Member2020 — 2022Lexington, Massachusetts, United States
- VaccinexBoard Member2013 — 2022
- Voyager Therapeutics, Inc.CFO2016Cambridge, MA
- Voyager Therapeutics, Inc.SVP, Finance & Business Development2013 — 2016Cambridge, MA
- Synageva BioPharma Corp.VP, Business Development2013Greater Boston
- Evercore PartnersManaging Director2013Greater Boston
- Evercore PartnersVP, Healthcare, M&A Advisory2008 — 2013
- Cowen & CompanyVP, Equity Research, Specialty Pharmaceuticals2004 — 2008
- VaccinexDirector, Business Development2000 — 2004
Skills & more
Corporate Finance8Start-ups9Corporate Development15Valuation6Mergers & Acquisitions27Due Diligence12Business Development23Licensing2Venture Capital7Investment Banking4M&A experience2Emerging Markets1
+4 more
Private EquityIPOFinancial ModelingBiotechnologyFrom Jeff's professional profile.
Deals · 2
RYNE Biotechnology Inc.Board seat
via The Column Group · filed Mar 2024 · $81.8M raise
Ribon TherapeuticsBoard seat
via The Column Group · filed Dec 2022 · $25M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Per SEC Form D filings.
Colleagues at The Column Group
Aadit Shah
Principal at The Column Group
Arnav Mehta, MD, PhD
Venture Partner at The Column Group
Carla Daniel
Partner at The Column Group
Craig Parker
Venture Partner at The Column Group
Hui Tian
Partner at The Column Group
Hui Tian, PhD
Partner at The Column Group
James Evangelista
Partner and CFO at The Column Group
JeenJoo Kang
Venture Partner at The Column Group
Network1
Investors connected to Jeff in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Jeff Goater?
- Jeff Goater leverages a career from research scientist to Evercore investment banker to biotech CEO, bringing deep technical, company-building expertise and a hands-on style as executive chair or interim CEO.
- Where does Jeff Goater work?
- Jeff Goater is Partner at The Column Group and Board director at RYNE Biotechnology Inc. and Board director at Remix Therapeutics.
- What does Jeff Goater invest in?
- Jeff Goater invests in Biotech, Healthtech.
- What check size does Jeff Goater write?
- Jeff Goater typically writes checks of $100K – $5M.
- What boards does Jeff Goater sit on?
- Jeff Goater holds tracked board seats at Remix Therapeutics, Ribon Therapeutics, RYNE Biotechnology Inc..
- Where did Jeff Goater go to school?
- Jeff Goater studied at University of Rochester - Simon Business School (MBA); University of Rochester School of Medicine and Dentistry (MS, Microbiology / Immunology); University of Rochester School of Medicine and Dentistry (MS, Pathology).
Founder mafias
University of Rochester mafia18
Also came through, then founded or led a company.
Sunil DhaliwalFounded SuplariDavid NarrowB.S.Founded SonavexDan GoldsmithBSFounded InstructureEric BallMAFounded CapConnect+Tao FuMSFounded Attovia TherapeuticsCraig DubitskyBAFounded Seventhgeneration
+ 11 more
Evercore mafia13
Also came through, then founded or led a company.
Fernando Lelo de Larrea H.VicepresidentFounded FondeadoraLucia HuangInvestment Banking AnalystFounded OsmindDivyang AroraAssociate, TMT (Tech Media Telecom)Founded Byte KitchenJoanne WangInvestment BankingFounded Copper HealthSamantha WuInvestment Banking AnalystFounded Understood CareDominik MiddelmannM&A AnalystFounded mdhub
+ 6 more
Kallyope mafia5
Also came through, then founded or led a company.
University of Rochester - Simon Business School mafia3
Also came through, then founded or led a company.
Judo Bio mafia2
Also came through, then founded or led a company.
Same school
Also attended University of Rochester - Simon Business School38
Camila VieiraPartner, Head of Brazil at QED InvestorsAndy WeymannVenture Partner, Frontiers in Health & Bio Investments at Verve VenturesWei JiangFounder & Managing Partner at CatchLight Capital PartnersJohn MurrayManaging Director, Portfolio Management and Business Development at EJF VenturesTim JonesPartner at ICISurya ManthaManaging Partner at Capria Ventures
+ 32 more
Also attended University of Rochester School of Medicine and Dentistry6
Also attended University of Rochester82
Michael OdaiCOO & General Counsel at Mosaic VenturesHal PazInvestor at Khosla VenturesCamila VieiraPartner, Head of Brazil at QED InvestorsBryan CiambellaGeneral Partner at PROOFWilliam SheahanSenior Vice President and Chief Innovation Officer at Flare Capital PartnersArtur BergmanFounder, Fastly at Amplify Partners
.png)
+ 76 more
Shared employers
Also worked at Tortugas Neuroscience4
Also worked at NILO Therapeutics1
Also worked at Kallyope8
Josh WolfePartner and Co-Founder at Lux CapitalIan PeikonVenture Partner at Lux CapitalRami HannoushVenture Partner at Versant VenturesDidem AltopGeneral Partner at Treeo VCDusan PerovicPartner at Two Sigma VenturesAdam GoulburnFounder and Managing Partner at Dimension Capital
+ 2 more
Also worked at Ribon Therapeutics6
Anja KoenigGlobal Head of NVF at Novartis Venture FundMarian NakadaVice President, Venture Investments at JJDCAnja KönigGlobal Head at Novartis Venture FundChristian SchubertHead of AbbVie Ventures at AbbVieJodie MorrisonVenture Partner at Atlas VentureMarian NakadaVice President at Johnson & Johnson Innovation – JJDC
